Citations (137)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Maria B. Garcia-Fabiani, Maria Ventosa, Andrea Comba, Marianela Candolfi, Alejandro J. Nicola Candia, Mahmoud S. Alghamri, Padma Kadiyala, Stephen Carney, Syed M. Faisal, Anna Schwendeman, James J. Moon, Lindsay Scheetz, Joerg Lahann, Ava Mauser, Pedro R. Lowenstein & Maria G. Castro. (2020) Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development. Expert Opinion on Investigational Drugs 29:7, pages 659-684.
Read now
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Read now
Adam M. Swartz, Steven H. Shen, Miguel A. Salgado, Kendra L. Congdon & Luis Sanchez-Perez. (2018) Promising vaccines for treating glioblastoma. Expert Opinion on Biological Therapy 18:11, pages 1159-1170.
Read now
Read now
Narayanasamy Badrinath, Jeong Heo & So Young Yoo. (2016) Viruses as nanomedicine for cancer. International Journal of Nanomedicine 11, pages 4835-4847.
Read now
Read now
Cherif Akladios & Marc Aprahamian. (2016) Virotherapy of digestive tumors with rodent parvovirus: overview and perspectives. Expert Opinion on Biological Therapy 16:5, pages 645-653.
Read now
Read now
Narendiran Rajasekaran, Cariad Chester, Atsushi Yonezawa, Xing Zhao & Holbrook E Kohrt. (2015) Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment. ImmunoTargets and Therapy 4, pages 91-100.
Read now
Read now
Seong-Ho Hong, Sung-Jin Park, Somin Lee, Chong Su Cho & Myung-Haing Cho. (2015) Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy. Expert Opinion on Drug Delivery 12:6, pages 977-991.
Read now
Read now
Amber C Miller & Stephen J Russell. (2014) Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors. Virus Adaptation and Treatment 6, pages 11-31.
Read now
Read now
Stephen Bradley, Adam D Jakes, Kevin Harrington, Hardev Pandha, Alan Melcher & Fiona Errington-Mais. (2014) Applications of coxsackievirus A21 in oncology. Oncolytic Virotherapy 3, pages 47-55.
Read now
Read now
James R Tysome, Nick R Lemoine & Yaohe Wang. (2013) Update on oncolytic viral therapy – targeting angiogenesis. OncoTargets and Therapy 6, pages 1031-1040.
Read now
Read now
José I. Quetglas, Liza B. John, Michael H. Kershaw, Luis Álvarez-Vallina, Ignacio Melero, Phillip K. Darcy & Cristian Smerdou. (2012) Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. OncoImmunology 1:8, pages 1344-1354.
Read now
Read now
Keith A. Lawson & Don G. Morris. (2012) Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?. Expert Opinion on Biological Therapy 12:7, pages 891-903.
Read now
Read now
Z Sheng Guo. (2011) The impact of hypoxia on oncolytic virotherapy. Virus Adaptation and Treatment 3, pages 71-82.
Read now
Read now
Patrycja J Lech & Stephen J Russell. (2010) Use of attenuated paramyxoviruses for cancer therapy. Expert Review of Vaccines 9:11, pages 1275-1302.
Read now
Read now
Articles from other publishers (123)
Simran Deep Kaur, Aman Deep Singh & Deepak N. Kapoor. (2023) Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy. Medical Oncology 40:7.
Crossref
Crossref
Yang Bo & Hua Wang. (2023) Biomaterial‐Based In Situ Cancer Vaccines. Advanced Materials.
Crossref
Crossref
Nadia Ghasemi Darestani, Anna I. Gilmanova, Moaed E. Al-Gazally, Angelina O. Zekiy, Mohammad Javed Ansari, Rahman S. Zabibah, Mohammed Abed Jawad, Saif A. J. Al-Shalah, Jasur Alimdjanovich Rizaev, Yasir S. Alnassar, Naseer Mihdi Mohammed, Yasser Fakri Mustafa, Mohammad Darvishi & Reza Akhavan-Sigari. (2023) Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Communication and Signaling 21:1.
Crossref
Crossref
Rui Ma, Zhenlong Li, E. Antonio Chiocca, Michael A. Caligiuri & Jianhua Yu. (2023) The emerging field of oncolytic virus-based cancer immunotherapy. Trends in Cancer 9:2, pages 122-139.
Crossref
Crossref
Yuan Yuan, Colt Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Lin, Helen Chang, Leslie Mi Ok Chong, Amanda Seiz, Monil Shah, W. Hans Meisen, Aileen Tang, Norma Martinez, Wichanee Pickett, Mireya Murga, Susan E. Yost, Daphne Stewart, Jianying Zhang, Nicholas Ede, Badri Modi, Jonathan Kessler, Jamie Rand & Yuman Fong. (2023) CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. Therapeutic Advances in Medical Oncology 15.
Crossref
Crossref
Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz & María Rodriguez-Ruiz. 2023. Radiation Oncology and Radiotherapy Part C. Radiation Oncology and Radiotherapy Part C
81
92
.
Phei Er Saw & Erwei Song. 2023. Tumor Ecosystem. Tumor Ecosystem
675
701
.
Nasrin Rastegarvand, Hoorieh Soleimanjahi, Ehsan Arefian & Mahmoud Reza Pourkarim. (2022) Application of Bioinformatics Tools for the Prediction of Helper MicroRNAs for Improvement of Oncolytic Virus Efficacy. Cellular Microbiology 2022, pages 1-9.
Crossref
Crossref
Yulia Ammour, Olga Susova, George Krasnov, Eugenia Nikolaeva, Vyacheslav Varachev, Yulia Schetinina, Marina Gavrilova, Alexey Mitrofanov, Anna Poletaeva, Ali Bekyashev, Evgeny Faizuloev, Vitaly V. Zverev, Oxana A. Svitich & Tatiana V. Nasedkina. (2022) Transcriptome Analysis of Human Glioblastoma Cells Susceptible to Infection with the Leningrad-16 Vaccine Strain of Measles Virus. Viruses 14:11, pages 2433.
Crossref
Crossref
Ximei Xu, Yin Xiang, Yang Yang, Kai Liu, Zhiwei Cui, Xiaodong Tong, Junliang Chen, Fang Hou & Zhiqiang Luo. (2022) The application of tumor cell-derived vesicles in oncology therapy. Clinical and Translational Oncology 25:2, pages 364-374.
Crossref
Crossref
Yijie Sun, Zhe Zhang, Chenglin Zhang, Na Zhang, Pengju Wang, Yongchao Chu, Louisa S. Chard Dunmall, Nicholas R. Lemoine & Yaohe Wang. (2022) An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition. Molecular Therapy - Oncolytics 26, pages 105-119.
Crossref
Crossref
Ghazal Asadi Garmaroudi, Farzaneh Karimi, Leila Ghanbari Naeini, Pajman Kokabian & Nozar Givtaj. (2022) Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective. Oxidative Medicine and Cellular Longevity 2022, pages 1-14.
Crossref
Crossref
Lihong Wang, Louisa S Chard Dunmall, Zhenguo Cheng & Yaohe Wang. (2022) Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment. Journal for ImmunoTherapy of Cancer 10:5, pages e004167.
Crossref
Crossref
Yanwei ChenShichuan HuYongheng ShuZhongbing QiBin ZhangYueting KuangJinhu MaPing Cheng. (2022) Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment. Human Gene Therapy 33:5-6, pages 237-249.
Crossref
Crossref
Lishu Chen, Chao Zhou, Qi Chen, Jingzhe Shang, Zhaodan Liu, Yan Guo, Chunfeng Li, HongJiang Wang, Qing Ye, XiaoFeng Li, Shulong Zu, Fangye Li, Qing Xia, Tao Zhou, Ailing Li, Chenhui Wang, Yun Chen, Aiping Wu, Chengfeng Qin & Jianghong Man. (2022) Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma. Molecular Therapy - Oncolytics 24, pages 522-534.
Crossref
Crossref
Soonbum Kwon & Yoon Yeo. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
483
528
.
Irina Alekseenko, Alexey Kuzmich, Liya Kondratyeva, Sofia Kondratieva, Victor Pleshkan & Eugene Sverdlov. (2021) Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement. International Journal of Molecular Sciences 22:17, pages 9376.
Crossref
Crossref
Worapol Ngamcherdtrakul, Moataz Reda, Molly A. Nelson, Ruijie Wang, Husam Y. Zaidan, Daniel S. Bejan, Ngoc Ha Hoang, Ryan S. Lane, Shiuh‐Wen Luoh, Sancy A. Leachman, Gordon B. Mills, Joe W. Gray, Amanda W. Lund & Wassana Yantasee. (2021) In Situ Tumor Vaccination with Nanoparticle Co‐Delivering CpG and STAT3 siRNA to Effectively Induce Whole‐Body Antitumor Immune Response. Advanced Materials 33:31, pages 2100628.
Crossref
Crossref
Noma Susan Senekal, Khaphetsi Joseph Mahasa, Amina Eladdadi, Lisette de Pillis & Rachid Ouifki. (2021) Natural Killer Cells Recruitment in Oncolytic Virotherapy: A Mathematical Model. Bulletin of Mathematical Biology 83:7.
Crossref
Crossref
Ángela-Patricia Hernández, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Halin Bareke, Enrique Montalvillo, Rafael Góngora & Manuel Fuentes. (2021) Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers 13:11, pages 2821.
Crossref
Crossref
Valentina Marchica, Federica Costa, Gaetano Donofrio & Nicola Giuliani. (2021) Oncolytic Virotherapy and Microenvironment in Multiple Myeloma. International Journal of Molecular Sciences 22:5, pages 2259.
Crossref
Crossref
Manlio Fusciello, Erkko Ylösmäki & Vincenzo Cerullo. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy
317
325
.
Malin Peter & Florian Kühnel. (2020) Oncolytic Adenovirus in Cancer Immunotherapy. Cancers 12:11, pages 3354.
Crossref
Crossref
Susanne Berchtold, Julia Beil, Christian Raff, Irina Smirnow, Martina Schell, Janina D’Alvise, Silvia Gross & Ulrich M. Lauer. (2020) Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines. International Journal of Molecular Sciences 21:20, pages 7618.
Crossref
Crossref
Maaly Bassiony, Adedoyin Victoria Aluko & James A. Radosevich. 2020. Precision Medicine in Oncology. Precision Medicine in Oncology
133
156
.
Amblessed E. Onuma, Hongji Zhang, Hai Huang, Terence M. Williams, Anne Noonan & Allan Tsung. (2020) Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment. Gene Expression 20:1, pages 53-65.
Crossref
Crossref
Ana Lemos de Matos, Lina S. Franco & Grant McFadden. (2020) Oncolytic Viruses and the Immune System: The Dynamic Duo. Molecular Therapy - Methods & Clinical Development 17, pages 349-358.
Crossref
Crossref
Sarah Aref, Anna Z. Castleton, Katharine Bailey, Richard Burt, Aditi Dey, Daniel Leongamornlert, Rachel J. Mitchell, Dina Okasha & Adele K. Fielding. (2020) Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus. Molecular Therapy 28:4, pages 1043-1055.
Crossref
Crossref
Altijana Hromic-Jahjefendic & Kenneth Lundstrom. (2020) Viral Vector-Based Melanoma Gene Therapy. Biomedicines 8:3, pages 60.
Crossref
Crossref
Ulrich M. Lauer, Can Yurttas & Julia Beil. 2020. Cancer Regional Therapy. Cancer Regional Therapy
17
26
.
Rūta Veinalde. 2020. Oncolytic Viruses. Oncolytic Viruses
213
227
.
Qingfeng Chen, Jiaxu Wang, Wai Nam Liu & Yue Zhao. (2019) Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms. Translational Oncology 12:7, pages 987-995.
Crossref
Crossref
Alireza Mohebbi, Mir Saeed Ebrahimzadeh, Sanaz Baghban Rahimi, Mohsen Saeidi, Alijan Tabarraei, Seyed Reza Mohebbi, Sadegh Shirian, Ali Gorji & Amir Ghaemi. (2019) Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression. Virus Research 261, pages 72-80.
Crossref
Crossref
Mee Rie Sheen & Steven Fiering. (2018)
In situ
vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree
. WIREs Nanomedicine and Nanobiotechnology 11:1.
Crossref
Crossref
Stacy J. Kowalsky, Zuqiang Liu, Mathilde Feist, Sara E. Berkey, Congrong Ma, Roshni Ravindranathan, Enyong Dai, Edward J. Roy, Zong Sheng Guo & David L. Bartlett. (2018) Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade. Molecular Therapy 26:10, pages 2476-2486.
Crossref
Crossref
Julia V Cockle & Karen J Scott. (2018) What is oncolytic virotherapy?. Archives of disease in childhood - Education & practice edition 103:1, pages 43-45.
Crossref
Crossref
Adrianne Jennera, Chae-Ok Yun, Arum Yoon, Adelle Coster & Peter Kim. (2018) Modelling Combined Virotherapy and Immunotherapy: Strengthening the Antitumour Immune Response Mediated by IL-12 and GM-CSF Expression. Letters in Biomathematics 5:2.
Crossref
Crossref
Adrianne Jenner, Adelle Coster, Peter Kim & Federico Frascoli. (2018) Treating Cancerous Cells with Viruses: Insights from Aminimal Model for Oncolytic Virotherapy. Letters in Biomathematics 5:2.
Crossref
Crossref
Assia Angelova, Milena Barf, Karsten Geletneky, Andreas Unterberg & Jean Rommelaere. (2017) Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity. Viruses 9:12, pages 382.
Crossref
Crossref
Bo-Kyeong Jung, Eonju Oh, JinWoo Hong, Yunki Lee, Ki Dong Park & Chae-Ok Yun. (2017) A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response. Biomaterials 147, pages 26-38.
Crossref
Crossref
Wojciech K. Panek, J. Robert Kane, Jacob S. Young, Aida Rashidi, Julius W. Kim, Deepak Kanojia & Maciej S. Lesniak. (2017) Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma. Oncotarget 8:51, pages 89391-89405.
Crossref
Crossref
Omid Hamid, Brianna Hoffner, Eduard Gasal, Jenny Hong & Richard D. Carvajal. (2017) Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer. Cancer Immunology, Immunotherapy 66:10, pages 1249-1264.
Crossref
Crossref
Sachin R. Jhawar, Aditya Thandoni, Praveen K. Bommareddy, Suemair Hassan, Frederick J. Kohlhapp, Sharad Goyal, Jason M. Schenkel, Ann W. Silk & Andrew Zloza. (2017) Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies. Frontiers in Oncology 7.
Crossref
Crossref
Zong Guo & David Bartlett. (2017) Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer. Biomedicines 5:3, pages 52.
Crossref
Crossref
Julia V. Cockle, Anke Brüning-Richardson, Karen J. Scott, Jill Thompson, Timothy Kottke, Ewan Morrison, Azam Ismail, Angel M. Carcaboso, Ailsa Rose, Peter Selby, Joe Conner, Susan Picton, Susan Short, Richard Vile, Alan Melcher & Elizabeth Ilett. (2017) Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion. Molecular Therapy - Oncolytics 5, pages 75-86.
Crossref
Crossref
Anna C. Filley & Mahua Dey. (2017) Immune System, Friend or Foe of Oncolytic Virotherapy?. Frontiers in Oncology 7.
Crossref
Crossref
Zong Sheng Guo, Zuqiang Liu, Stacy Kowalsky, Mathilde Feist, Pawel Kalinski, Binfeng Lu, Walter J. Storkus & David L. Bartlett. (2017) Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives. Frontiers in Immunology 8.
Crossref
Crossref
Virginia Bayer, Beau Amaya, Diane Baniewicz, Colleen Callahan, Lisa Marsh & Asia McCoy. (2017) Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice. Clinical Journal of Oncology Nursing 21:2, pages 13-21.
Crossref
Crossref
So Young Kim, Dongxu Kang, Hye Jin Choi, Yeonsoo Joo, Joo-Hang Kim & Jae J. Song. (2017) Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation. Oncotarget 8:9, pages 15858-15877.
Crossref
Crossref
Michael Melzer, Arturo Lopez-Martinez & Jennifer Altomonte. (2017) Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”. Biomedicines 5:4, pages 8.
Crossref
Crossref
Mourad Ferhat. (2017) Oncolytic Viruses: The Next Major Breakthrough in Cancer Treatment. Journal of Human Virology & Retrovirology 5:1.
Crossref
Crossref
M. Angela Aznar, Nicola Tinari, Antonio J. Rullán, Alfonso R. Sánchez-Paulete, María E. Rodriguez-Ruiz & Ignacio Melero. (2017) Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally. The Journal of Immunology 198:1, pages 31-39.
Crossref
Crossref
Donald Bastin, Scott Walsh, Meena Al Saigh & Yonghong Wan. (2016) Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies. Biomedicines 4:3, pages 21.
Crossref
Crossref
Li Ran, Xiaohua Tan, Yanchun Li, Huafeng Zhang, Ruihua Ma, Tiantian Ji, Wenqian Dong, Tong Tong, Yuying Liu, Degao Chen, Xiaonan Yin, Xiaoyu Liang, Ke Tang, Jingwei Ma, Yi Zhang, Xuetao Cao, Zhuowei Hu, Xiaofeng Qin & Bo Huang. (2016) Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials 89, pages 56-66.
Crossref
Crossref
Mari Hirvinen, Cristian Capasso, Kilian Guse, Mariangela Garofalo, Andrea Vitale, Marko Ahonen, Lukasz Kuryk, Markus Vähä-Koskela, Akseli Hemminki, Vittorio Fortino, Dario Greco & Vincenzo Cerullo. (2016) Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity. Molecular Therapy - Oncolytics 3, pages 16002.
Crossref
Crossref
C Parrish, G B Scott, G Migneco, K J Scott, L P Steele, E Ilett, E J West, K Hall, P J Selby, D Buchanan, A Varghese, M S Cragg, M Coffey, P Hillmen, A A Melcher & F Errington-Mais. (2015) Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia 29:9, pages 1799-1810.
Crossref
Crossref
Adel H. Jebar, Richard G. Vile, Alan A. Melcher, Stephen Griffin, Peter J. Selby & Fiona Errington-Mais. (2015) Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma. Journal of General Virology 96:7, pages 1533-1550.
Crossref
Crossref
Holly E. Barker, James T. E. Paget, Aadil A. Khan & Kevin J. Harrington. (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nature Reviews Cancer 15:7, pages 409-425.
Crossref
Crossref
Yang Yan, Songyan Li, Tingting Jia, Xiaohui Du, Yingxin Xu, Yunshan Zhao, Li Li, Kai Liang, Wentao Liang, Huiwei Sun & Rong Li. (2015) Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity. Tumor Biology 36:6, pages 4535-4543.
Crossref
Crossref
Joseph Malinzi, Precious Sibanda & Hermane Mambili-Mamboundou. (2015) Analysis of virotherapy in solid tumor invasion. Mathematical Biosciences 263, pages 102-110.
Crossref
Crossref
Y M El-Sherbiny, T D Holmes, L F Wetherill, E V I Black, E B Wilson, S L Phillips, G B Scott, R A Adair, R Dave, K J Scott, R S M Morgan, M Coffey, G J Toogood, A A Melcher & G P Cook. (2015)
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells
in vivo
. Clinical and Experimental Immunology 180:1, pages 98-107.
Crossref
Crossref
Mari HirvinenMaria RajeckiMika KapanenSuvi ParviainenNoora Rouvinen-LagerströmIulia DiaconuPetri NokisalmiMikko TenhunenAkseli HemminkiVincenzo Cerullo. (2015) Immunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus. Human Gene Therapy 26:3, pages 134-144.
Crossref
Crossref
Suvi Parviainen, Marko Ahonen, Iulia Diaconu, Anja Kipar, Mikko Siurala, Markus Vähä-Koskela, Anna Kanerva, Vincenzo Cerullo & Akseli Hemminki. (2015) GMCSF-armed vaccinia virus induces an antitumor immune response. International Journal of Cancer 136:5, pages 1065-1072.
Crossref
Crossref
Chunyan Li, Gang Meng, Lei Su, Aiping Chen, Mao Xia, Chun Xu, Decai Yu, Aiqin Jiang & Jiwu Wei. (2014) Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma. Oncotarget 6:3, pages 1544-1555.
Crossref
Crossref
Zheng Chai, Peiyi Zhang, Fang Fu, Xueyun Zhang, Ying Liu, Lihua Hu & Xi Li. (2014) Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer. Virology Journal 11:1.
Crossref
Crossref
Stephanie A. Lamb, Masmudur M. Rahman & Grant McFadden. (2014) Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulence. Virology 464-465, pages 134-145.
Crossref
Crossref
Andrew Nguyen, Louisa Ho & Yonghong Wan. (2014) Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Ivaylo Gentschev, Sandeep Patil, Ivan Petrov, Joseph Cappello, Marion Adelfinger & Aladar Szalay. (2014) Oncolytic Virotherapy of Canine and Feline Cancer. Viruses 6:5, pages 2122-2137.
Crossref
Crossref
Shashi A. Gujar & Patrick W. K. Lee. (2014) Oncolytic Virus-Mediated Reversal of Impaired Tumor Antigen Presentation. Frontiers in Oncology 4.
Crossref
Crossref
Emma Spurrell, Rathi Gangeswaran, Pengju Wang, Fengyu Cao, Dongling Gao, Baisui Feng, William Wold, Ann Tollefson, Nicholas R. Lemoine & Yaohe Wang. (2014) STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus. Journal of Virology 88:4, pages 2291-2300.
Crossref
Crossref
Satoshi Takeda, Daiki Kanbayashi, Takako Kurata, Hironori Yoshiyama & Jun Komano. (2014)
Enhanced susceptibility of
B
lymphoma cells to measles virus by
E
pstein–
B
arr virus type
III
latency that upregulates
CD
150/signaling lymphocytic activation molecule
. Cancer Science 105:2, pages 211-218.
Crossref
Crossref
Yang Yan, Yingxin Xu, Yunshan Zhao, Li Li, Peiming Sun, Hailiang Liu, Qinghao Fan, Kai Liang, Wentao Liang, Huiwei Sun, Xiaohui Du & Rong Li. (2013) Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model. Tumor Biology 35:2, pages 1113-1122.
Crossref
Crossref
H Inoue & K Tani. (2013) Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death & Differentiation 21:1, pages 39-49.
Crossref
Crossref
Yu-Ping Liu, Michael B. Steele, Lukkana Suksanpaisan, Mark J. Federspiel, Stephen J. Russell, Kah Whye Peng & Jamie N. Bakkum-Gamez. (2014) Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer. Gynecologic Oncology 132:1, pages 194-202.
Crossref
Crossref
Jahangir Ahmed, Ming Yuan, Ghassan Alusi, Nicholas R. Lemoine & Yaohe Wang. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
225
238
.
Mari Hirvinen, Raita Heiskanen, Minna Oksanen, Saila Pesonen, Ilkka Liikanen, Timo Joensuu, Anna Kanerva, Vincenzo Cerullo & Akseli Hemminki. (2013) Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment. Journal of Translational Medicine 11:1.
Crossref
Crossref
David L Bartlett, Zuqiang Liu, Magesh Sathaiah, Roshni Ravindranathan, Zongbi Guo, Yukai He & Zong Sheng Guo. (2013) Oncolytic viruses as therapeutic cancer vaccines. Molecular Cancer 12:1.
Crossref
Crossref
Bei Zhang, Yuan Liu, Xiuju Wang, Ling Jiang, Zhigang Lu, Xing Zhang, Kunpeng Li & Haiyan Hu. (2013)
A novel recombinant
Salmonella
vaccine enhances the innate immunity of NK cells against acute myeloid leukaemia cells Kasumi-1 in vitro
. Cell Biology International 37:12, pages 1320-1329.
Crossref
Crossref
Ellen M. Vollmers & Peter Tattersall. (2013) Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses. Virology 446:1-2, pages 37-48.
Crossref
Crossref
Yu-Ping Liu, Lukkana Suksanpaisan, Michael B. Steele, Stephen J. Russell & Kah-Whye Peng. (2013) Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy. Scientific Reports 3:1.
Crossref
Crossref
Julia V Cockle, Susan V Picton & Alan Melcher. (2013) Future clinical potential of oncolytic virotherapy for pediatric CNS tumors. CNS Oncology 2:4, pages 307-310.
Crossref
Crossref
Christian GrossardtChristine E. EngelandSascha BossowNiels HalamaKarim ZaouiMathias F. LeberChristoph SpringfeldDirk JaegerChristof von KalleGuy Ungerechts. (2013) Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine. Human Gene Therapy 24:7, pages 644-654.
Crossref
Crossref
Robert A. Adair, Karen J. Scott, Sheila Fraser, Fiona Errington‐Mais, Hardev Pandha, Matt Coffey, Peter Selby, Graham P. Cook, Richard Vile, Kevin J. Harrington, Giles Toogood & Alan A. Melcher. (2012) Cytotoxic and immune‐mediated killing of human colorectal cancer by reovirus‐loaded blood and liver mononuclear cells. International Journal of Cancer 132:10, pages 2327-2338.
Crossref
Crossref
Pragatheeshwar Thirunavukarasu, Magesh Sathaiah, Michael C Gorry, Mark E O'Malley, Roshni Ravindranathan, Frances Austin, Steven H Thorne, Zong Sheng Guo & David L Bartlett. (2013) A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis. Molecular Therapy 21:5, pages 1024-1033.
Crossref
Crossref
Stephanie Weibel, Thomas Christian Basse-Luesebrink, Michael Hess, Elisabeth Hofmann, Carolin Seubert, Johanna Langbein-Laugwitz, Ivaylo Gentschev, Volker Jörg Friedrich Sturm, Yuxiang Ye, Thomas Kampf, Peter Michael Jakob & Aladar A. Szalay. (2013) Imaging of Intratumoral Inflammation during Oncolytic Virotherapy of Tumors by 19F-Magnetic Resonance Imaging (MRI). PLoS ONE 8:2, pages e56317.
Crossref
Crossref
James R. Tysome, Xiaozhu Li, Shengdian Wang, Pengju Wang, Dongling Gao, Pan Du, Dong Chen, Rathi Gangeswaran, Louisa S. Chard, Ming Yuan, Ghassan Alusi, Nicholas R. Lemoine & Yaohe Wang. (2012) A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity. Clinical Cancer Research 18:24, pages 6679-6689.
Crossref
Crossref
S Naik, R Nace, M J Federspiel, G N Barber, K-W Peng & S J Russell. (2012) Curative one-shot systemic virotherapy in murine myeloma. Leukemia 26:8, pages 1870-1878.
Crossref
Crossref
T Granot & D Meruelo. (2012) The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan. Cancer Gene Therapy 19:8, pages 588-591.
Crossref
Crossref
Fabrice Le Boeuf, Nima Niknejad, Jiahu Wang, Rebecca Auer, Johanne I. Weberpals, John C. Bell & Jim Dimitroulakos. (2012) Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: Potential role of human papilloma virus infection. International Journal of Cancer 131:3, pages E204-E215.
Crossref
Crossref
Ding WeiNa SunGang NanYuan WangHong-Qi LiuBen PeetersZhi-Nan ChenHuijie Bian. (2012) Construction of Recombinant Newcastle Disease Virus Italien Strain for Oncolytic Virotherapy of Tumors. Human Gene Therapy 23:7, pages 700-710.
Crossref
Crossref
Ulrike Gerdemann, Martin Pulé & Malcolm K. Brenner. 2013. Childhood Leukemias. Childhood Leukemias
593
615
.
Kenneth H. Kim, Igor Dmitriev, Janis P. O'Malley, Minghui Wang, Souheil Saddekni, Zhiying You, Meredith A. Preuss, Raymond D. Harris, Rosemarie Aurigemma, Gene P. Siegal, Kurt R. Zinn, David T. Curiel & Ronald D. Alvarez. (2012) A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer. Clinical Cancer Research 18:12, pages 3440-3451.
Crossref
Crossref
Robert A. AdairVictoria RoulstoneKaren J. ScottRuth MorganGerard J. NuovoMartin FullerDeborah BeirneEmma J. WestVictoria A. JenningsAilsa RoseJoan KyulaSheila FraserRajiv DaveDavid A. AnthoneyAlison MerrickRobin PrestwichAmer AldouriOliver DonnellyHardev PandhaMatt CoffeyPeter SelbyRichard VileGiles ToogoodKevin HarringtonAlan A. Melcher. (2012) Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients. Science Translational Medicine 4:138.
Crossref
Crossref
Iulia Diaconu, Vincenzo Cerullo, Mari L.M. Hirvinen, Sophie Escutenaire, Matteo Ugolini, Saila K. Pesonen, Simona Bramante, Suvi Parviainen, Anna Kanerva, Angelica S.I. Loskog, Aristides G. Eliopoulos, Sari Pesonen & Akseli Hemminki. (2012) Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus. Cancer Research 72:9, pages 2327-2338.
Crossref
Crossref
Sari Pesonen, Iulia Diaconu, Lotta Kangasniemi, Tuuli Ranki, Anna Kanerva, Saila K. Pesonen, Ulrike Gerdemann, Ann M. Leen, Kalevi Kairemo, Minna Oksanen, Elina Haavisto, Sirkka-Liisa Holm, Aila Karioja-Kallio, Satu Kauppinen, Kaarina P. L. Partanen, Leena Laasonen, Tima Joensuu, Tuomo Alanko, Vincenzo Cerullo & Akseli Hemminki. (2012) Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients. Cancer Research 72:7, pages 1621-1631.
Crossref
Crossref
K B Stephenson, N G Barra, E Davies, A A Ashkar & B D Lichty. (2011) Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity. Cancer Gene Therapy 19:4, pages 238-246.
Crossref
Crossref
CHIEKO YOSHIHARA, KATSUYUKI HAMADA, MINAKO KURODA & YOSHIYUKI KOYAMA. (2012) Oncolytic plasmid: A novel strategy for tumor immuno-gene therapy. Oncology Letters 3:2, pages 387-390.
Crossref
Crossref
Pong-Yu Huang, Jih-Huong Guo & Lih-Hwa Hwang. (2012) Oncolytic Sindbis Virus Targets Tumors Defective in the Interferon Response and Induces Significant Bystander Antitumor Immunity In Vivo. Molecular Therapy 20:2, pages 298-305.
Crossref
Crossref
Vincenzo Cerullo, Anniina Koski, Markus Vähä-Koskela & Akseli Hemminki. 2012. Applications of viruses for cancer therapy. Applications of viruses for cancer therapy
265
318
.
Liu Xin-Yuan, Wen-Lin Huang, Qi-Jun Qian, Wei-Guo Zou, Zi-Lai Zhang, Liang Chu, Kang-Jian Zhang, Li-Li Zhao, Yan-Hong Zhang, Song-Bo Qiu, Zhen-Wei Zhang, Tian Xiao, Jun-Kai Fan, Na Wei, Xin-Ran Liu, Xin Cao, Jin-Fa Gu, Rui-Cheng Wei, Miao Ding & Shuai Wu. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy
33
83
.
Lynette Steele, Fiona Errington, Robin Prestwich, Elizabeth Ilett, Kevin Harrington, Hardev Pandha, Matt Coffey, Peter Selby, Richard Vile & Alan Melcher. (2011) Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Molecular Cancer 10:1.
Crossref
Crossref
Stephanie Weibel, Viktoria Raab, Yong A Yu, Andrea Worschech, Ena Wang, Francesco M Marincola & Aladar A Szalay. (2011) Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection. BMC Cancer 11:1.
Crossref
Crossref
Timothy Kottke, Fiona Errington, Jose Pulido, Feorillo Galivo, Jill Thompson, Phonphimon Wongthida, Rosa Maria Diaz, Heung Chong, Elizabeth Ilett, John Chester, Hardev Pandha, Kevin Harrington, Peter Selby, Alan Melcher & Richard Vile. (2011) Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine 17:7, pages 854-859.
Crossref
Crossref
Caroline J Breitbach, Naomi S De Silva, Theresa J Falls, Usaf Aladl, Laura Evgin, Jennifer Paterson, Yang Yang Sun, Dominic G Roy, Julia L Rintoul, Manijeh Daneshmand, Kelley Parato, Marianne M Stanford, Brian D Lichty, Aaron Fenster, David Kirn, Harold Atkins & John C Bell. (2011) Targeting Tumor Vasculature With an Oncolytic Virus. Molecular Therapy 19:5, pages 886-894.
Crossref
Crossref
Sari Pesonen, Lotta Kangasniemi & Akseli Hemminki. (2010) Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data. Molecular Pharmaceutics 8:1, pages 12-28.
Crossref
Crossref
Phonphimon Wongthida, Rosa M Diaz, Feorillo Galivo, Timothy Kottke, Jill Thompson, Alan Melcher & Richard Vile. (2011) VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling. Molecular Therapy 19:1, pages 150-158.
Crossref
Crossref
Candice Willmon, Rosa M Diaz, Phonphimon Wongthida, Feorillo Galivo, Timothy Kottke, Jill Thompson, Steven Albelda, Kevin Harrington, Alan Melcher & Richard Vile. (2011) Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide. Molecular Therapy 19:1, pages 140-149.
Crossref
Crossref
Lotta Kangasniemi & Akseli Hemminki. (2010) Oncolytic adenovirus research and applications. Future Virology 5:6, pages 745-761.
Crossref
Crossref
Nanhai G Chen & Aladar A Szalay. (2010) Oncolytic vaccinia virus: a theranostic agent for cancer. Future Virology 5:6, pages 763-784.
Crossref
Crossref
Kathryn HallMaria E. Blair ZajdelG. Eric Blair. (2010) Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy. Biochemical Journal 431:3, pages 321-336.
Crossref
Crossref
Mirei Kanzaki, Takashi Okamoto, Hiroshi Mitsui, Naotaka Shibagaki & Shinji Shimada. (2010) A novel immunotherapeutic approach to melanoma-bearing hosts with protein-transduction domain-containing immunogenic foreign antigens. Journal of Dermatological Science 60:2, pages 84-94.
Crossref
Crossref
Jeong-Hun Kang, Riki Toita & Yoshiki Katayama. (2010) Bio and nanotechnological strategies for tumor-targeted gene therapy. Biotechnology Advances 28:6, pages 757-763.
Crossref
Crossref
Gerd R. Silberhumer, Peter Brader, Joyce Wong, Inna S. Serganova, Mithat Gönen, Segundo Jaime Gonzalez, Ronald Blasberg, Dmitriy Zamarin & Yuman Fong. (2010) Genetically Engineered Oncolytic Newcastle Disease Virus Effectively Induces Sustained Remission of Malignant Pleural Mesothelioma. Molecular Cancer Therapeutics 9:10, pages 2761-2769.
Crossref
Crossref
Yu-Qian Zhang, Ya-Chea Tsai, Archana Monie, T.-C. Wu & Chien-Fu Hung. (2010) Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy. Molecular Therapy 18:4, pages 692-699.
Crossref
Crossref
Nicolas BoisgeraultFrédéric TangyMarc Gregoire. (2010) New perspectives in cancer virotherapy: bringing the immune system into play. Immunotherapy 2:2, pages 185-199.
Crossref
Crossref
Mathieu H.M. Noteborn. (2009) Proteins selectively killing tumor cells. European Journal of Pharmacology 625:1-3, pages 165-173.
Crossref
Crossref
Robin J. Prestwich, Fiona Errington, Lynette P. Steele, Elizabeth J. Ilett, Ruth S. M. Morgan, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile & Alan A. Melcher. (2009) Reciprocal Human Dendritic Cell–Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus. The Journal of Immunology 183:7, pages 4312-4321.
Crossref
Crossref
Martina RiederKarl-Klaus Conzelmann. (2009) Rhabdovirus Evasion of the Interferon System. Journal of Interferon & Cytokine Research 29:9, pages 499-510.
Crossref
Crossref
Robin J. Prestwich, Elizabeth J. Ilett, Fiona Errington, Rosa M. Diaz, Lynette P. Steele, Tim Kottke, Jill Thompson, Feorillo Galivo, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile & Alan A. Melcher. (2009) Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication. Clinical Cancer Research 15:13, pages 4374-4381.
Crossref
Crossref
Ramon AlemanyManel Cascallo. (2009) Oncolytic viruses from the perspective of the immune system. Future Microbiology 4:5, pages 527-536.
Crossref
Crossref
Thi Lien-Anh Nguyen, Vanessa Fonseca Tumilasci, Diane Singhroy, Meztli Arguello & John Hiscott. (2009) The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies. Cellular Microbiology 11:6, pages 889-897.
Crossref
Crossref
Sebastian Tuve, Ying Liu, Khajornsak Tragoolpua, Jeffrey Daniel Jacobs, Roma Christine Yumul, Zong-Yi Li, Robert Strauss, Karl-Erik Hellström, Mary Lenora Disis, Steve Roffler & André Lieber. (2009) In situ adenovirus vaccination engages T effector cells against cancer. Vaccine 27:31, pages 4225-4239.
Crossref
Crossref
E J Ilett, R J Prestwich, T Kottke, F Errington, J M Thompson, K J Harrington, H S Pandha, M Coffey, P J Selby, R G Vile & A A Melcher. (2009) Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene Therapy 16:5, pages 689-699.
Crossref
Crossref